Merck to help produce new Johnson & Johnson vaccine

In an unusual deal, drugmaker Merck will help produce Johnson & Johnson’s newly-authorized one-shot COVID-19 vaccine. The agreement was facilitated by the Biden administration after Johnson & Johnson fell behind with production.

Merck is one of the world’s largest vaccine makers, but abandoned development of its own vaccine in January after shots failed to activate the right immune response. With Merck’s help, Johnson & Johnson is now expected to meet a production commitment of 100 million doses by the end of June.

WATCH: Gov. Murphy directs Johnson & Johnson COVID-19 vaccine to minority communities

MORE: NJ officials, who once feared vaccine hesitancy, nowhere near meeting demand for COVID-19 immunization

We’re in this together
For a better-informed future. Support our nonprofit newsroom.
Donate to NJ Spotlight